Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome. The gene discussed is FOLH1; the disease is metastatic prostate carcinoma.